Table 1. Moderate to severe anemia in... | American Society of Hematology

Table 1.

Moderate to severe anemia in malaria

									Hb, g/L
Patient	Age, y	Sex	Site	Hb type	G-6-PD	Infected RBCs × 10⁶/L (%)^*	Treatment	Treatment failure	Baseline	At treatment	Lowest	Time to lowest
1	0.7	M	D	AA	Normal	3 500 (—)	P/Su	No	95	53	53	0 d
2	1.0	M	D	AA	Normal	509 000 (30.6)	Q	No	94	53	43	3 d
3	1.0	F	D	AS	Normal	176 000 (6.9)	Q	?	104	82	59	3 d
4A†	2.0	F	D	AA	Normal	214 000 (8.9)	P/Su	No	96	77	44	3 d
4B†	2.2	F	D	AA	Normal	145 000 (4.9)	Q	No	96	95	54	7 d
5	2.5	F	D	AA	Normal	264 000 (9.6)	P/Su	No	104	88	48	7 d
6	3.2	F	D	AA	Normal	15 025 (—)	None	—	86	—	53	—
7	1.6	M	S	AC	Normal	170 000 (6.6)	C	Yes	89	82	49	14 d
8	2.0	F	S	AA	Low	9 600(—)	P/Su,C	No	89	83	52	14 d

									Hb, g/L
Patient	Age, y	Sex	Site	Hb type	G-6-PD	Infected RBCs × 10⁶/L (%)^*	Treatment	Treatment failure	Baseline	At treatment	Lowest	Time to lowest
1	0.7	M	D	AA	Normal	3 500 (—)	P/Su	No	95	53	53	0 d
2	1.0	M	D	AA	Normal	509 000 (30.6)	Q	No	94	53	43	3 d
3	1.0	F	D	AS	Normal	176 000 (6.9)	Q	?	104	82	59	3 d
4A†	2.0	F	D	AA	Normal	214 000 (8.9)	P/Su	No	96	77	44	3 d
4B†	2.2	F	D	AA	Normal	145 000 (4.9)	Q	No	96	95	54	7 d
5	2.5	F	D	AA	Normal	264 000 (9.6)	P/Su	No	104	88	48	7 d
6	3.2	F	D	AA	Normal	15 025 (—)	None	—	86	—	53	—
7	1.6	M	S	AC	Normal	170 000 (6.6)	C	Yes	89	82	49	14 d
8	2.0	F	S	AA	Low	9 600(—)	P/Su,C	No	89	83	52	14 d

Hb indicates hemoglobin; D, Donéguébougou; —, not done; P/Su, pyrimethamine/sulfadoxine (Fansidar); Q, quinine; ?, unknown; S, Sotuba; and C, chloroquine.

Infected RBCs at time of treatment, expressed as number/μL blood and as percent infected (estimated from hemoglobin and number per μL).

†

Same patient at 2 years (A) and 2 months later (B).

View Large

This Feature Is Available To Subscribers Only